Apoptosis of Human Burkitt’s Lymphoma Cells Induced by 2-N,NDiethylaminocarbonyloxymethyl-1-diphenylmethyl-4-(3,4,5-trimethoxybenzoyl) piperazine Hydrochloride (PMS-1077)

다국어 초록 (Multilingual Abstract)

Piperazine is one of the heterocycles which are associated with diverse pharmacological activities. 2-N,N-Diethylaminocarbonyloxymethyl-1-diphenylmethyl-4-(3,4,5-trimethoxybenzoyl) piperazine hydrochloride (PMS-1077) is a trisubstituted piperazine which contains a trimethoxybenzene
ring and a benzhydrylpiperazine fragment, both of which can induce cell proliferation regression by different mechanisms. We have therefore examined the effects of PMS-1077 on Human Burkitt’s lymphoma cells (Raji). The viability of Raji cells was determined by MTT assay and also assessed by trypan blue dye exclusion method. The results demonstrate that PMS-1077 can suppress the proliferation of Raji cells in a dose- and timedependent
manner, while inhibit colony formation ability of Raji cells merely in a dose-dependent manner in vitro. Meanwhile, morphological changes were observed using fluorescence microscope. Flow cytometric analysis through PI stains showed that PMS-1077 blocked the growth of Raji cells in the G0/G1 period, and induced apoptosis of Raji cells after 48 h of incubation.
Cell apoptosis induced by PMS-1077 was further confirmed by staining with Annexin-V FITC and PI. Preliminary study by molecular docking suggests that PMS-1077 may inhibit tubulin polymerization. More experiments are in progress in our laboratory to reveal the mode of action of PMS-1077 in the induction of apoptosis of Raji cells.

참고문헌 (Reference)

• 1 Kasibhatla, S., "Why target apoptosis in cancer treatment?" 2 : 573-580, 2003
• 2 Pettersen, E. F., "UCSF Chimera--a visualization system for exploratory research and analysis" 25 : 1605-1612, 2004
• 3 Ghobrial, I. M., "Targeting apoptosis pathways in cancer therapy" 55 : 178-194, 2005
• 4 Bremer, E., "Targeted induction of apoptosis for cancer therapy: current progress and prospects" 12 : 382-393, 2006
• 5 Kumar, C. S., "Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines" 2008
• 6 Serradji, N., "Structureactivity relationships in platelet-activating factor. in: Part 13: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity" 14 : 8109-8125, 2006
• 7 Serradji, N., "Structure-activity relationships in platelet-activating factor. in: 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity" 47 : 6410-6419, 2004
• 8 Sallem, W., "Structure-activity relationships in platelet-activating factor. Part 14: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity" 14 : 7999-8013, 2006
• 9 Serradji, N., "Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication" 43 : 2149-2154, 2000
• 10 Miao, R., "Selenopodophyllotoxin derivatives induce hepatoma SMMC- 7721 cell apoptosis through Bax pathway" 32 : 217-223, 2008
• 11 Guex, N., "SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling" 18 : 2714-2723, 1997
• 12 Joseph, B., "Role of apoptosis in the response of lung carcinomas to anticancer treatment" 926 : 204-216, 2000
• 13 Surh, Y. J., "Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL- 60) cells" 140 : 1-10, 1999
• 14 A Orjales, J. G.-S., "R Corcostegui Synthesis and histamine HI-receptor antagonist activity of 4-(diphenylmethyl)- 1-piperazine derivatives with a terminal heteroaryl or cycloalkyl amide fragment" 31 : 813-818, 1996
• 15 Delano, W. L., "PyMol Molecular Graphics System, DeLano Scientific" 2002
• 16 Wang, X., "Potential anticancer activity of litchi fruit pericarp extract against hepatocellular carcinoma in vitro and in vivo" 239 : 144-150, 2006
• 17 Martin, M., "PMS-601, a new plateletactivating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. Antimicrob" 44 : 3150-3154, 2000
• 18 Garrett, M., "Olson automated docking using a lamarckian genetic algorithm and an empirical binding free energy function" 19 : 1639-1662, 1998
• 19 Martelli, A. M., "Nuclear apoptotic changes: an overview" 82 : 634-646, 2001
• 20 Alvarez, C., "Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation" 16 : 8999-9008, 2008b
• 21 Saraste, A., "Morphologic and biochemical hallmarks of apoptosis" 45 : 528-537, 2000
• 22 Samaha, H. S., "Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion" 57 : 1301-1305, 1997
• 23 Doudican, N., "Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells" 6 : 1308-1315, 2008
• 24 Rosin, M. P., "Inflammation, chromosomal instability, and cancer: the schistosomiasis model" 54 : 1929s-1993s, 1994
• 25 Mantovani, A., "Inflammation and cancer: breast cancer as a prototype" 16 (16): S27-33, 2007
• 26 Lu, M. C., "Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells" 73 : 2378-2383, 2006
• 27 Hoessel, R., "Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases" 1 : 60-67, 1999
• 28 Ye, C. L., "In vitro anti-tumor activity of 2',4'-dihydroxy-6'-methoxy- 3',5'-dimethylchalcone against six established human cancer cell lines" 50 : 505-510, 2004
• 29 Yuan, S. L., "Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells" 10 : 2024-2028, 2004
• 30 Van Der Spoel, D., "GROMACS: fast, flexible, and free" 26 : 1701-1718, 2005
• 31 Darzynkiewicz, Z., "Features of apoptotic cells measured by flow cytometry" 13 : 795-808, 1992
• 32 Bernhard, D., "Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEMC7H2 lymphocytic leukemia cells" 195 : 193-199, 2003
• 33 Alvarez, C., "Diarylmethyloxime and hydrazone derivatives with 5-indolyl moieties as potent inhibitors of tubulin polymerization" 16 : 5952-5961, 2008a
• 34 Cheng, X. C., "Design, synthesis, and biological activities of novel Ligustrazine derivatives" 15 : 3315-3320, 2007
• 35 Ghosh, P., "Cytotoxic and apoptogenic effect of tea (Camellia sinensis var. assamica) root extract (TRE) and two of its steroidal saponins TS1 and TS2 on human leukemic cell lines K562 and U937 and on cells of CML and ALL patients" 30 : 459-468, 2006
• 36 Lau, C. B., "Cytotoxic activities of Coriolus versicolor (Yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis" 75 : 797-808, 2004
• 37 Bellosillo, B., "Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells" 92 : 1406-1414, 1998
• 38 Wilson, M. R., "Apoptosis: unmasking the executioner" 5 : 646-652, 1998
• 39 Vermeulen, K., "Apoptosis: mechanisms and relevance in cancer" 84 : 627-639, 2005
• 40 Kiechle, F. L., "Apoptosis: biochemical aspects and clinical implications" 326 : 27-45, 2002
• 41 Kerr, J. F., "Apoptosis. in: Its significance in cancer and cancer therapy" 73 : 2013-2026, 1994
• 42 Thompson, C. B., "Apoptosis in the pathogenesis and treatment of disease" 267 : 1456-1462, 1995
• 43 Sgonc, R., "Apoptosis detection: an overview" 33 : 525-533, 1998
• 44 Schmitt, C. A., "Apoptosis and therapy" 187 : 127-137, 1999
• 45 Krysko, D. V., "Apoptosis and necrosis: detection, discrimination and phagocytosis" 44 : 205-221, 2008
• 46 Mchugh, P., "Apoptosis and necrosis: a review for surgeons" 7 : 53-68, 2006
• 47 Sellers, W. R., "Apoptosis and cancer drug targeting" 104 : 1655-1661, 1999
• 48 Makin, G., "Apoptosis and cancer chemotherapy" 301 : 143-152, 2000
• 49 Lin, C. M., "Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin" 28 : 6984-6991, 1989
• 50 Los, M., "Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design" 8 : 67-77, 2003
• 51 Koopman, G., "Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis" 84 : 1415-1420, 1994
• 52 Owa, T., "A focused compound library of novel N-(7- indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors" 10 : 1223-1226, 2000
• 53 Jiang, J. D., "3-(Iodoacetamido)- benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells" 58 : 5389-5395, 1998